Baxter Healthcare Corporation is recalling 60,594 units of Regadenoson Injection (0.4 mg/5 mL), a prescription medication used during cardiac stress tests. This voluntary recall was initiated because certain single-dose pre-filled syringes may be missing their required product identification labels. Healthcare providers and pharmacies should immediately check their inventory for the affected lot numbers and contact the manufacturer or their distributor to arrange for a return.
A missing label on a pre-filled syringe can lead to dangerous medication errors, as healthcare staff may be unable to verify the drug name, strength, or concentration before administration. This could result in a patient receiving the wrong medication or an incorrect dosage.
Firm initiated recall via letter notification.
Recall #: D-0039-2025; Manufactured by Baxter Pharmaceutical Solutions, LLC; Manufactured for Baxter Healthcare Corporation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.